Randall, M., Rauschecker, A., Chen, L., Lu, M., Roselli, J., Ruiz, R., Abdulhaq, H., Rubenstein, J. (2025). Interim analysis of a Phase I/II study of tafasitamab with lenalidomide in patients with relapsed central nervous system lymphoma. Blood. https://doi.org/10.1182/blood-2025-1969